Tech Company Financing Transactions

SenoRx Funding Round

On 6/30/2006, SenoRx announced $8 million in funding from De Novo Ventures and SunAmerica Ventures.

Transaction Overview

Company Name
Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1625 West 3rd St.
Tempe, AZ 85281
USA
Email Address
Overview
SenoRx was founded in 1998 to design, develop, manufacture and market minimally invasive devices for the diagnosis and treatment of breast cancer. Since its founding, SenoRx has developed multiple, proprietary technology platforms and a unique product portfolio that address the entire range of diagnostic and therapeutic procedures.
Profile
SenoRx LinkedIn Company Profile
Social Media
SenoRx Company Twitter Account
Company News
SenoRx News
Facebook
SenoRx on Facebook
YouTube
SenoRx on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Lloyd Malchow
   Lloyd Malchow LinkedIn Profile   Lloyd Malchow Twitter Account   Lloyd Malchow News   Lloyd Malchow on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2006: Oorja Protonics venture capital transaction
Next: 6/30/2006: Market Velocity venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary